4//SEC Filing
Hoenlein Malcolm 4
Accession 0001104659-21-048824
CIK 0001429260other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 5:22 PM ET
Size
5.3 KB
Accession
0001104659-21-048824
Insider Transaction Report
Form 4
Hoenlein Malcolm
Director
Transactions
- Award
Common Stock
2021-01-01+50,000→ 435,000 total
Footnotes (2)
- [F1]One-third of the shares will vest on each of January 1, 2022, 2023 and 2024, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer.
- [F2]The total holdings include 350,000 shares underlying deferred restricted stock units.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001294517
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 5:22 PM ET
- Size
- 5.3 KB